[1. Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet. 2012; 380(9844):848-857.10.1016/S0140-6736(12)60605-9]Search in Google Scholar
[2. Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet. 2017; 390(10091):298-310.10.1016/S0140-6736(16)32407-2]Search in Google Scholar
[3. Perry AM, Diebold J, Nathwani BN et al. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the International non-Hodgkin Lymphoma Classification Project. Ann Hematol. 2016; 95(2):245-251.10.1007/s00277-015-2543-426537613]Search in Google Scholar
[4. Perry AM, Diebold J, Nathwani BN et al. Non-Hodgkin Lymphoma In The Developing World: Review Of 4539 Cases From The International Non-Hodgkin Lymphoma Classification Project. Haematologica. 2016; 101(10):1244-1250.10.3324/haematol.2016.148809504665427354024]Search in Google Scholar
[5. Bogliș A, Radu CG, Tripon F et al. XRCC1 Arg194Trp and Arg399Gln Polymorphisms and Risk of Non-Hodgkin Lymphoma in a Romanian Population. Rev Med Chir Soc Med Nat Iasi. 2016; 120(3):644-650.]Search in Google Scholar
[6. Bogliș A, Crauciuc AG, Tripon F et al. No association between GSTT1, GSTM1 and GSTP1 gene polymorphism and risk of non-Hodgkin lymphoma in a population from Romania. International Journal of Innovation and Applied Studies. 2017; 19(1):1-8.]Search in Google Scholar
[7. Dotlic S, Perry AM, Petrusevska G et al. Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin classification project. Br J Haematol. 2015; 171(3):366-372.10.1111/bjh.1358626213902]Search in Google Scholar
[8. Moriya K, Tamura H, Nakamura K, Hosone M, Inokuchi K. A primary esophageal MALT lymphoma patient with Helicobacter pylori infection achieved complete remission after H. pylori eradication without anti-lymphoma treatment. Leuk Res Rep. 2017; 7:2-5.10.1016/j.lrr.2016.12.001]Search in Google Scholar
[9. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010; 49 (11):1603-1616.10.1016/j.freeradbiomed.2010.09.006299047520840865]Search in Google Scholar
[10. Lightfoot TJ, Skibola CF, Smith AG et al. Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin’s lymphoma. Haematologica. 2006; 91(9):1222-1227.]Search in Google Scholar
[11. Baecklund E, Iliadou A, Askling J et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006; 54(3):692-701.10.1002/art.2167516508929]Search in Google Scholar
[12. Callan MF. Epstein-Barr virus, arthritis, and the development of lymphoma in arthritis patients. Curr Opin Rheumatol. 2004; 16(4):399-405.10.1097/01.bor.0000126149.96627.8215201603]Search in Google Scholar
[13. Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C virus, Sjogren’s syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev. 2005; 4(1):8-15.10.1016/j.autrev.2004.04.00415652773]Search in Google Scholar
[14. Laurent A, Nicco C, Chéreau C et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res. 2005; 65(3):948–956.10.1158/0008-5472.948.65.3]Search in Google Scholar
[15. SNPedia database. Catalase gene. Avaiable at https://www.snpedia.com/index.php?title=Special%3ASearch&search=catalase&fulltext=1. Last time accessed on 27 January, 2019.]Search in Google Scholar
[16. NCBI. Catalase gene. Available from http://ncbi.nlm.nih.gov/gene847. Last time accessed on 27 January, 2019.]Search in Google Scholar
[17. Wang CD, Sun Y, Chen N et al. The Role of Catalase C262T Gene Polymorphism in the Susceptibility and Survival of Cancers. Sci Rep. 2016; 6:26973.10.1038/srep26973488092227225983]Search in Google Scholar
[18. Bănescu C, Iancu M, Trifa AP et al. From Six Gene Polymorphisms of the Antioxidant System, Only GPX Pro198Leu and GSTP1 Ile105Val Modulate the Risk of Acute Myeloid Leukemia. Oxid Med Cell Longev. 2016; 6:1-10.10.1155/2016/2536705470732526823947]Search in Google Scholar
[19. Farawela H, Khorshied M, Shaheen I et al. The association between hepatitis C virus infection, genetic polymorphisms of oxidative stress genes and B-cell non-Hodgkin’s lymphoma risk in Egypt. Infect Genet Evol. 2012; 12(6):1189–1194.10.1016/j.meegid.2012.04.00722522002]Search in Google Scholar
[20. Ekoue DN, Bera S, Ansong E et al. Allelic variations in MnSOD and GPx-1 affect metabolism, mitochondrial membrane potential and expression of signaling proteins. Proceedings of the AACR 107th Annual Meeting 2016; April 16-20; New Orleans, LA: Cancer Res; 2016; 76(14).10.1158/1538-7445.AM2016-225]Search in Google Scholar
[21. Wang SS, David S, Cerhan JR et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis. 2006; 27(9):1828-1834.10.1093/carcin/bgl01316543247]Search in Google Scholar
[22. Paz-y-Miño C, Muñoz MJ, López-Cortés A et al. Frequency of polymorphisms Pro198Leu in GPX-1 gene and Ile58Thr in MnSOD gene in the altitude Ecuadorian population with bladder cancer. Oncol Res. 2010; 18(8):395–400.10.3727/096504010X12644422320780]Search in Google Scholar
[23. Bănescu C, Trifa AP, Voidăzan S et al. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study. Oxid Med Cell Longev. 2014; 2014: 875861.10.1155/2014/875861424313525436036]Search in Google Scholar
[24. Negovan A, Iancu M, Tripon F, Crauciuc A, Mocan S, Bănescu C. The CAT-262 C>T, MnSOD Ala16Val, GPX1 Pro198Leu Polymorphisms Related to Oxidative Stress and the Presence of Gastric Lesions. J Gastrointestin Liver Dis. 2018; 27(4):371-378.10.15403/jgld.2014.1121.274.cat30574618]Search in Google Scholar
[25. Nogai H, Dörken B, Lenz G. Pathogenesis of Non-Hodgkin’s Lymphoma. J Clin Oncol. 2011; 29(14):1803-1811.10.1200/JCO.2010.33.325221483013]Search in Google Scholar
[26. Al-Alem U, Gann PH, Dahl J et al. Associations between functional polymorphisms in antioxidant defense genes and urinary oxidative stress biomarkers in healthy, premenopausal women. Genes Nutr. 2012; 7(2):191–195.10.1007/s12263-011-0257-3331674622068340]Search in Google Scholar
[27. Yuzhalin AE, Kutikhin AG. Inherited variations in the SOD and GPX gene families and cancer risk. Free Radic Res. 2012; 46(5):581–599.10.3109/10715762.2012.65851522257147]Search in Google Scholar
[28. Ahn J, Nowell S, McCann SE et al. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev. 2006; 15(6):1217-1222.10.1158/1055-9965.EPI-06-010416775184]Search in Google Scholar
[29. Skibola CF, Curry JD, Nieters A. Genetic Susceptibility to Lymphoma. Haematologica. 2007; 92(7):960-969.10.3324/haematol.11011281916517606447]Search in Google Scholar
[30. Kang SW. Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis. Int J Clin Exp Med. 2015; 8(9):14647-14655.]Search in Google Scholar
[31. Bewick M, Coutie W, Tudhope GR. Superoxide dismutase, glutathione peroxidase and catalase in the red cells of patients with malignant lymphoma. Br J Haematol. 1987; 65(3):347–350.10.1111/j.1365-2141.1987.tb06866.x3567087]Search in Google Scholar
[32. Van Remmen H, Ikeno Y, Hamilton M et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics. 2003; 16(1):29-37.10.1152/physiolgenomics.00122.200314679299]Search in Google Scholar